NCT07316257

Brief Summary

This work aims at elucidating the role of MRI complementary T2 mapping in assessment of the articular knee cartilage for improving sensitivity of detection of early stage of osteoarthritis

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
9mo left

Started Jan 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Jan 2026Feb 2027

First Submitted

Initial submission to the registry

December 16, 2025

Completed
16 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2027

Expected
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 16, 2025

Last Update Submit

December 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • This work aims at elucidating the role of MRI complementary T2 mapping to measure the changes in T2 relaxation time of the articular knee cartilage in healthy group which there number will be 28 and pateints with early osteoarthritis there number 28

    to detect the value of adding T2 mapping to routine MRI in assessment of the articular cartilage in knee osteoarthritis

    baseline

Secondary Outcomes (1)

  • This work aims at quantitive stratification of osteoarthrtic changes and its impact on treatement

    baseline

Interventions

MRIDEVICE

Device that use coil to image asses the articular cartilage of the knee

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

any patient with knee pain with no history of previous lustrophobiaoperation and has no metallic element inside his body with no ca

You may qualify if:

  • patients with clinical evidence of osteoarthritis

You may not qualify if:

  • contraindications for MRI such as claustrophobia, heart pacemaker and ferromagnetic implants
  • patients in which the misaligned images or distortions due to motion artifacts made the interpretation of the MRI unreliable.
  • Patients with previous knee operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Le J, Peng Q, Sperling K. Biochemical magnetic resonance imaging of knee articular cartilage: T1rho and T2 mapping as cartilage degeneration biomarkers. Ann N Y Acad Sci. 2016 Nov;1383(1):34-42. doi: 10.1111/nyas.13189. Epub 2016 Jul 29.

    PMID: 27472534BACKGROUND
  • Gao S, Peng C, Wang G, Deng C, Zhang Z, Liu X. Cartilage T2 mapping-based radiomics in knee osteoarthritis research: Status, progress and future outlook. Eur J Radiol. 2024 Dec;181:111826. doi: 10.1016/j.ejrad.2024.111826. Epub 2024 Nov 8.

    PMID: 39522425BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Abeer Houssein Ali, prof.dr

    Assiut University

    STUDY DIRECTOR
  • Ahmed Moustafa Mohamed, prof

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Shrouk Mohamed Gad, MSC

CONTACT

zahraa sayed hassan, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DR

Study Record Dates

First Submitted

December 16, 2025

First Posted

January 5, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

January 12, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

January 5, 2026

Record last verified: 2025-12